Searched by
Class I
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TC-0101-4 |
HLA-B*15:01 EBV EBNA4 Tetramer-GQGGSPTAM-BV421 |
|
|||
|
virus | BV421 | B*15:01 | 50 tests |
0 (Contact us) |
|
| GQGGSPTAM | 4°C | |||||
|
TC-0177-4 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLQSLQTYV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLQSLQTYV | 4°C | |||||
|
TS-0027-4C |
HLA-B*35:01 CMV pp65 Tetramer-IPSINVHHY-BV421 |
|
|||
|
virus | BV421 | B*35:01 | 50 tests |
0 (Contact us) |
|
| IPSINVHHY | 123-131 | 4°C | ||||
|
TC-0157-2 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | 4°C | ||||
|
TC-0145-2 |
HLA-B*08:01 HCV NS3 Tetramer-HSKKKCDEL-APC |
|
|||
|
virus | APC | B*08:01 | 50 tests |
0 (Contact us) |
|
| HSKKKCDEL | 4°C | |||||
|
TS-M142-4 |
HLA-B*07:02 EBV EBNA3A Tetramer-RPPIFIRRL-BV421 |
|
|||
|
virus | BV421 | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPPIFIRRL | 4°C | |||||
|
TC-0166-2 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| ALLAVGATK | 4°C | |||||
|
TC-0154-1 |
HLA-A*02:01 HHV-8 gB Tetramer-LMWYELSKI-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMWYELSKI | 4°C | |||||
|
TS-0019-4C |
HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMDGTMSQV | 4°C | |||||
|
TS-5010-4C |
H-2Kb LCMV gp34-41 Tetramer-AVYNFATC-BV421 |
|
|||
|
virus | BV421 | H-2Kb | 50 tests |
0 (Contact us) |
|
| AVYNFATC | 34-41 | 4°C | ||||
|
TC-0174-2 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLNEVAKNL | 4°C | |||||
|
TS-M538-4 |
H-2Kb VACV B8R Tetramer-TSYKFESV-BV421 |
|
|||
|
virus | BV421 | H-2Kb | 50 tests |
0 (Contact us) |
|
| TSYKFESV | 20-27 | 4°C | ||||
|
TC-0144-1 |
HLA-B*07:02 H-Y Tetramer-SPSVDKARAEL-PE |
|
|||
|
Others | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| SPSVDKARAEL | 4°C | |||||
|
TS-M528-4 |
H-2Db Influenza PA Tetramer-SSLENFRAYV-BV421 |
|
|||
|
virus | BV421 | H-2Db | 50 tests |
0 (Contact us) |
|
| SSLENFRAYV | 4°C | |||||
|
TC-0137-2 |
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-APC |
|
|||
|
virus | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLCLRFLSK | 64-72 | 4°C | ||||
|
TS-M039-2 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| CINGVCWTV | 1073-1081 | 4°C | ||||
|
TC-0105-4 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-BV421 |
|
|||
|
cancer | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLFGVLRLK | 4°C | |||||
|
TC-0130-1 |
HLA-A*24:02 HIV env Tetramer-RYLKDQQLL-PE |
|
|||
|
virus | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| RYLKDQQLL | 67-75 | 4°C | ||||
|
TC-5105-4 |
H-2Kd MAGE-A3 Tetramer-SYVKVLHHM-BV421 |
|
|||
|
cancer | BV421 | H-2Kd | 50 tests |
0 (Contact us) |
|
| SYVKVLHHM | 4°C | |||||
|
TC-0129-2 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-APC |
|
|||
|
cancer | APC | B*35:01 | 50 tests |
0 (Contact us) |
|
| MPFATPMEA | 94-102 | 4°C | ||||
|
TC-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | 4°C | ||||
|
TC-5103-4 |
H-2Kb T. gondii tgd057 Tetramer-SVLAFRRL-BV421 |
|
|||
|
Others | BV421 | H-2Kb | 50 tests |
0 (Contact us) |
|
| SVLAFRRL | 4°C | |||||
|
TC-0126-4 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-BV421 |
|
|||
|
cancer | BV421 | A*01:01 | 50 tests |
0 (Contact us) |
|
| KSDICTDEY | 243-251 | 4°C | ||||
|
TS-M051-4 |
HLA-A*02:01 HBV env 335-343 Tetramer-WLSLLVPFV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| WLSLLVPFV | 335-343 | 4°C | ||||
|
TC-0145-1 |
HLA-B*08:01 HCV NS3 Tetramer-HSKKKCDEL-PE |
|
|||
|
virus | PE | B*08:01 | 50 tests |
0 (Contact us) |
|
| HSKKKCDEL | 4°C | |||||
|
TS-0015-4C |
HLA-A*02:01 Her-2/neu E75 Tetramer-KIFGSLAFL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KIFGSLAFL | 369-377 | 4°C | ||||
|
TS-M106-4 |
HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-BV421 |
|
|||
|
virus | BV421 | B*35:01 | 50 tests |
0 (Contact us) |
|
| VPLRPMTY | 74-81 | 4°C | ||||
|
TC-0131-1 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDKGTYTL | 276-284 | 4°C | ||||
|
TC-5102-2 |
H-2Kb Survivin Tetramer-MFFCFKEL-APC |
|
|||
|
cancer | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| MFFCFKEL | 4°C | |||||
|
TS-5014-2 |
H-2Kb LCMV L protein Tetramer-LEYDFNKL-APC |
|
|||
|
virus | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| LEYDFNKL | 825-832 | 4°C | ||||
|
TC-0105-2 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLFGVLRLK | 4°C | |||||
|
TC-0175-4 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPDDFTGCV | 4°C | |||||
|
TS-0031-2 |
HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPET-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests | 1-9 | |
| YMLDLQPET | 11-19 | 4°C | ||||
|
TS-M539-4 |
H-2Db SV40 large T Ag 206-215 Tetramer-SAINNYAQKL-BV421 |
|
|||
|
virus | BV421 | H-2Db | 50 tests |
0 (Contact us) |
|
| SAINNYAQKL | 206-215 | 4°C | ||||
|
TS-M033-4 |
HLA-A*03:01 EBV EBNA3A 603-611 Tetramer-RLRAEAQVK-BV421 |
|
|||
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| RLRAEAQVK | 603-611 | 4°C | ||||
|
TC-0122-1 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTRILTI | 4°C | |||||
|
TC-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LTLGEFLKL | 96-104 | 4°C | ||||
|
TC-0120-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTV | 4°C | |||||
|
TC-0154-2 |
HLA-A*02:01 HHV-8 gB Tetramer-LMWYELSKI-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMWYELSKI | 4°C | |||||
|
TC-0167-1 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-PE |
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| RYCNLEGPPI | 177-186 | 4°C | ||||
|
TC-0125-2 |
HLA-A*01:01 HCV polyprotein Tetramer-ATDALMTGY-APC |
|
|||
|
virus | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| ATDALMTGY | 4°C | |||||
|
TS-0012-4C |
HLA-A*02:01 Influenza-M1 Tetramer-GILGFVFTL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GILGFVFTL | 4°C | |||||
|
TS-M040-2 |
HLA-A*02:01 HCV NS3 1406-1415 Tetramer-KLVALGINAV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVALGINAV | 1406-1415 | 4°C | ||||
|
TC-0157-4 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | 4°C | ||||
|
TC-8006-1 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | 4°C | ||||
|
TS-M070-4 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | 4°C | ||||
|
TC-0109-4 |
HLA-A*03:01 HIV p17 gag Tetramer-RLRPGGKKK-BV421 |
|
|||
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| RLRPGGKKK | 4°C | |||||
|
TC-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | |||||
|
TC-0128-2 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | 4°C | ||||
|
TC-0159-4 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | 4°C | ||||
|
TS-M027-4 |
HLA-A*02:01 HIV gag Tetramer-SLYNTVATL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLYNTVATL | 77-85 | 4°C | ||||
|
TC-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQVNSLQTV | 4°C | |||||
|
TC-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | 4°C | ||||
|
TS-0016-2 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLLQETELV | 689-697 | 4°C | ||||
|
TC-0114-4 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQVNSLQTV | 4°C | |||||
|
TC-0121-1 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALPHIIDEV | 4°C | |||||
|
TC-0156-4 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | 4°C | ||||
|
TS-M124-4 |
HLA-A*03:01 EBV BRLF1 Tetramer-RVRAYTYSK-BV421 |
|
|||
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| RVRAYTYSK | 4°C | |||||
|
TC-0128-1 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | 4°C | ||||
|
TC-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | ||||
|
TC-0131-4 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDKGTYTL | 276-284 | 4°C | ||||
|
TS-M043-4 |
HLA-A*02:01 HCV NS5B 2594-2602 Tetramer-ALYDVVSKL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYDVVSKL | 2594-2602 | 4°C | ||||
|
TC-0118-1 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CVNGVCWTV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| CVNGVCWTV | 4°C | |||||
|
TC-0159-1 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | 4°C | ||||
|
TC-0161-1 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | 4°C | ||||
|
TC-0175-1 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPDDFTGCV | 4°C | |||||
|
TC-0135-4 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLADQLIHL | 101-109 | 4°C | ||||
|
TC-0146-1 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLEMLWRL | 125-133 | 4°C | ||||
|
TC-0113-1 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | |||||
|
TC-0133-4 |
HLA-A*02:01 HTLV bZIP Tetramer-AVLDGLLSL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVLDGLLSL | 42-50 | 4°C | ||||
|
TC-0132-1 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | ||||
|
TC-0135-2 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLADQLIHL | 101-109 | 4°C | ||||
|
TC-0142-4 |
HLA-B*07:02 HIV gag Tetramer-GPGHKARVL-BV421 |
|
|||
|
virus | BV421 | B*07:02 | 50 tests |
0 (Contact us) |
|
| GPGHKARVL | 223-231 | 4°C | ||||
|
TS-0016-4 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLLQETELV | 689-697 | 4°C | ||||
|
TS-M039-1 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| CINGVCWTV | 1073-1081 | 4°C | ||||
|
TC-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AILALLPAL | 105-133 | 4°C | ||||
|
TC-0150-1 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | 4°C | ||||
|
TC-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | 4°C | ||||
|
TC-0121-2 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALPHIIDEV | 4°C | |||||
|
TS-M040-4 |
HLA-A*02:01 HCV NS3 1406-1415 Tetramer-KLVALGINAV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVALGINAV | 1406-1415 | 4°C | ||||
|
TS-M072-2 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | 4°C | ||||
|
TC-0110-2 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLLFLLFSL | 4°C | |||||
|
TC-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | 4°C | ||||
|
TC-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | 4°C | ||||
|
TS-M107-4 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDVYNGLL | 299-307 | 4°C | ||||
|
TS-M076-2 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests | 1-9 | |
| FLWGPRALV | 271-279 | 4°C | ||||
|
TS-M082-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | 4°C | ||||
|
TC-8010-2 |
HLA-A*02:01 KRAS5-14 G12D Tetramer-KLVVVGADGV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGADGV | 5-14 | 4°C | ||||
|
TC-8006-2 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | 4°C | ||||
|
TC-8010-1 |
HLA-A*02:01 KRAS5-14 G12D Tetramer-KLVVVGADGV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGADGV | 5-14 | 4°C | ||||
|
TC-8031-1 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | ||||
|
TC-8003-2 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | ||||
|
TC-8002-1 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | 4°C | ||||
|
TS-M623-2 |
H-2Kd Insulin Tetramer-LYLVCGERG-APC |
|
|||
|
Others | APC | H-2Kd | 50 tests |
0 (Contact us) |
|
| LYLVCGERG | 39-47 | 4°C | ||||
|
TC-8001-2 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | ||||
|
TS-M621-2 |
H-2Kb Nischarin Tetramer-TNQDFIQRL-APC |
|
|||
|
Others | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| TNQDFIQRL | 600-608 | 4°C | ||||
|
TS-M250-2 |
HLA-A*02:01 EBV BRLF1 Tetramer-YVLDHLIVV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YVLDHLIVV | 109-117 | 4°C | ||||
|
TC-8026-2 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-APC |
|
|||
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | 4°C | ||||
|
TC-8030-1 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | ||||
|
TS-M247-2 |
HLA-A*02:01 AGMO Neoepitope Tetramer-ALLQVTLLL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLQVTLLL | 4°C | |||||